Patents Assigned to YANTAI RC BIOTECHNOLOGIES, LTD.
  • Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
    Patent number: 9522949
    Abstract: The present invention relates to angiogenesis-inhibitory fusion proteins and use thereof. Particularly, the present invention provides fusion proteins inhibiting a plurality of angiogenic factors. More particularly, the present invention relates to the fusion proteins of VEGF receptor and FGF receptor and their applications in the treatment of angiogenesis related diseases.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 20, 2016
    Assignee: YANTAI RC BIOTECHNOLOGIES, LTD.
    Inventors: Jianmin Fang, Dong Li